SCHEMBL7161037

SCHEMBL7161037

Nc1ccc(S(=O)(=O)NCCCBr)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.66
▸ CA9 Q16790 11/20 0.64
▸ CA1 P00915 11/20 0.64
▸ CA2 P00918 11/20 0.64
▸ CA12 O43570 10/20 0.64
▸ CYP2D6 P10635 1/20 0.60
▸ PRMT1 Q99873 1/20 0.57
▸ CA6 P23280 2/20 0.55
▸ CA5A P35218 2/20 0.55
▸ CA7 P43166 2/20 0.55
▸ CA5B Q9Y2D0 2/20 0.55
▸ CA14 Q9ULX7 1/20 0.55
▸ ALDH1A1 P00352 4/20 0.51
▸ PKM P14618 3/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ CA4 P22748 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7092060 0.82 ALDH1A1 (0.70) CA9CA2CA12ALDH1A1MEN1
SCHEMBL4085333 0.82 CA12 (0.80) CYP3A4CA9CA1CA2CA12
SCHEMBL13357765 0.82 CYP3A4 (0.66) CYP3A4CA9CA1CA2CA12
SCHEMBL7532832 0.82 TSHR (0.63) CA1CA2ALDH1A1PKMMEN1
SCHEMBL28079518 0.82 CYP3A4 (0.66) CYP3A4CA9CA1CA2CA12
SCHEMBL14104604 0.81 ALDH1A1 (0.75) CA1CA2ALDH1A1PKMMEN1
SCHEMBL30380602 0.81 CYP2D6 (0.68) CYP3A4CA9CA1CA2CA12
SCHEMBL28736088 0.81 CYP3A4 (0.69) CYP3A4CA9CA1CA2CA12
SCHEMBL1082403 0.81 CA12 (0.77) CYP3A4CA9CA1CA2CA12
SCHEMBL14628032 0.79 CYP3A4 (1.00) CYP3A4CA9CA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1433297-A Topical compositions comprising protected functional thiols PROCTER & GAMBLE (US) 2003-07-30 — — CN disclosed
US-6544499-B1 Polysiloxane or silicone resin, a linker, and a molecular hook for treating amino acid based substrates; hair care THE PROCTER & GAMBLE COMPANY 2003-04-08 — — US disclosed
US-6495125-B2 MAY BE USED IN HAIR CARE, TEXTILE CARE, COSMETICS, ORAL CARE FORMULATIONS, SKIN, NAIL, LAUNDRY, ACNE CARE FORMULATIONS THE PROCTER & GAMBLE COMPANY 2002-12-17 — — US disclosed
US-20020012639-A1 May be used in hair care, textile care, cosmetics, oral care formulations, skin, nail, laundry, acne care formulations PROCTER & GAMBLE COMPANY, THE 2002-01-31 — — US disclosed
EP-1143916-A2 TOPICAL COMPOSITIONS COMPRISING PROTECTED FUNCTIONAL THIOLS THE PROCTER & GAMBLE COMPANY (US) 2001-10-17 — — EP disclosed
WO-2000040210-A2 TOPICAL COMPOSITIONS COMPRISING PROTECTED FUNCTIONAL THIOLS THE PROCTER & GAMBLE COMPANY (US) 2000-07-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020012639-A1 May be used in hair care, textile care, cosmetics, oral care formulations, skin, nail, laundry, acne care formulations SCLY, TST, SRR CYP3A4 1463/4885CA9 3325/4885CA1 3937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback